Marginum

Company Description

Marginum is a market forerunner in quantitative surgical techniques developing fluorescence-based optical tissue monitoring technologies. Backed by Redstone, Nostetta Ventures, Almaral and Business Finland, the company’s data-driven solutions enable monitoring of tissues during cancer surgery and treatments. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’s multidisciplinary team works in close cooperation with academic, clinical and industrial experts to ensure its technological solutions’ seamless clinical compatibility.